|
|
NephroSant, a kidney health spin out of UCSF, today announced that it has hired Gina Ford, RPh, MBA, as chief commercial officer to spearhead global commercialization strategy and bring QSantTM - the first and only urine-based kidney rejection test - to market. Ford brings 20 years of experience in life sciences and the pharmaceutical industry, having served leadership roles in corporate strategy, commercial, portfolio management and patient advocacy.
Gina Ford brings 20 years of experience in the life sciences and pharmaceutical industry and joined as our Vice President, Corporate Strategy, and Commercial Planning in March 2019. She has served leadership roles in portfolio management, commercial, market access, and corporate development.
Prior to joining Crinetics, Gina was principal of One Joule, LLC a commercial and corporate strategy consulting company that she founded, where she provided biopharmaceutical clients with strategic advice on corporate, commercial, marketing, and global market access strategy, including launch preparations, forecasting, market development, and KOL organization. She joined a One Joule client, AcelRx Pharmaceuticals, for a period of four years, as Vice President of Commercial Strategy, during which time she was instrumental in developing the global commercial strategy for AcelRx’s products. Before One Joule, Gina was Head of Endocrinology at Ipsen, where she was responsible for pediatric and adult endocrinology brands. She led efforts in sales, marketing, market access, finance, analytics, project management as well as patient services and reimbursement. Gina also served in leadership roles with Solstice Neurosciences and Elan Pharmaceuticals.
Gina Ford brings 20 years of experience in the life sciences and pharmaceutical industry and joined as our Vice President, Corporate Strategy, and Commercial Planning in March 2019. She has served leadership roles in portfolio management, commercial, market access, and corporate development.
Prior to joining Crinetics, Gina was principal of One Joule, LLC a commercial and corporate strategy consulting company that she founded, where she provided biopharmaceutical clients with strategic advice on corporate, commercial, marketing, and global market access strategy, including launch preparations, forecasting, market development, and KOL organization. She joined a One Joule client, AcelRx Pharmaceuticals, for a period of four years, as Vice President of Commercial Strategy, during which time she was instrumental in developing the global commercial strategy for AcelRx’s products. Before One Joule, Gina was Head of Endocrinology at Ipsen, where she was responsible for pediatric and adult endocrinology brands. She led efforts in sales, marketing, market access, finance, analytics, project management as well as patient services and reimbursement. Gina also served in leadership roles with Solstice Neurosciences and Elan Pharmaceuticals.
